LONDON, UK; 22 October 2018 – Consilium Strategic Communications, a global leader in strategic healthcare communications, congratulates its clients that have been shortlisted for an award at the 14th Annual Scrip Awards taking place on 28 November 2018 in London.
“The annual Scrip Awards provide the healthcare industry with an opportunity to acknowledge the highest achievers across the pharma and biotech industries and we are very proud to have a good variety of our clients shortlisted for these prestigious awards. We would like to wish all finalists, and particularly our clients, the best of luck and look forward to celebrating their achievements over the past year with them on the night.”
Mary-Jane Elliott
Managing Partner, Consilium Strategic Communications
Consilium’s clients have been shortlisted in the following categories:
Ablynx (now part of Sanofi)
- Financing Deal of the Year (public) – Ablynx’s $200m US IPO on NASDAQ
- IQVIA’s Clinical Advance of the Year Award – Ablynx’s Phase III HERCULES study of caplacizumab for acquired thrombotic thrombocytopenic purpura
- Executive of the Year (for Large & Medium Cap Companies) – Edwin Moses, CEO
Ergomed
- Best Technological Development in Clinical Trials – Ergomed/PrimeVigilance/Automation Anywhere’s robotic process automation software
Horizon Discovery
- Financing Deal of the Year (public) – Horizon Discovery Group’s £80m public placing
Polyphor
- Financing Deal of the Year (public) – Polyphor’s CHF165m IPO
TiGenix
- Executive of the Year (for Small Cap & Private Pharma Companies) – Eduardo Bravo, CEO
- Syneos Health’s Best New Drug Award – TiGenix’s Alofisel (darvadstrocel)
